View Cart  

Aug. 29, 2011

Vol. 3 No. 34

View Archived Issues

Sign Up Now

‘Worrisome Deficiencies’ Noted in Warning to Polish Drugmaker

The FDA has warned Polish pharmaceutical manufacturer Jelfa SA, citing “worrisome” cGMP deficiencies, including a number of repeat violations. Read More

FDA Warns Peace Medical for GMP Issues, Unapproved Devices

The FDA has warned Peace Medical for several GMP issues, including failure to provide design control procedures, and for marketing its devices without approval or agency consent. Read More

Unexpected Compound Levels Incite J&J Tylenol Recall

Johnson & Johnson (J&J) subsidiary McNeil Consumer Healthcare is again recalling Tylenol products, this time for higher-than-expected levels of a compound. Read More

Pharmaceutics International Successfully Completes EMA and FDA Inspection

Pharmaceutics International announced it has successfully completed the first-ever US-based joint European Medicines Agency and Food and Drug Administration inspection.  Read More

Teva Goes to Trial Over Hepatitis Cases Linked to Tainted Propofol Vials

Teva Pharmaceutical is facing a second trial over hepatitis cases linked to propofol. Read More

Ajanta Pharma Receives MHRA Approval for Aurangabad Facility

Ajanta Pharma said it has received approval from the UK health regulator for its formulation manufacturing facility in Aurangabad. Read More

Astellas Pharma to Relocate UK Headquarters to Chertsey

Astellas Pharma has closed a deal to relocate its base of UK operations to a new, larger site in Surrey. Read More

Job Figure for Cork Pharmaceutical Facility Raised to 250

A total of 250 jobs are to be created in the expansion of a pharmaceutical plant in Carrigtwohill, County Cork. Read More

Amgen to Create 100 Dublin Jobs

U.S. drug firm Amgen is to create 100 jobs at its factory in Dublin. Read More